Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000499393 | SCV000593051 | likely benign | not specified | 2018-03-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764249 | SCV000895254 | uncertain significance | ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001545023 | SCV001764269 | likely benign | not provided | 2020-04-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001545023 | SCV003502056 | uncertain significance | not provided | 2023-02-20 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with ADNP-related conditions. This variant is present in population databases (rs147299402, gnomAD 0.02%). This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 873 of the ADNP protein (p.Asp873Tyr). ClinVar contains an entry for this variant (Variation ID: 434095). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. |